Overall rank by patents
#13,124
Across all tracked assignees
USPTO PatentsView assignee record - 23 granted patents across 18 technology areas, active 2023–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G09F (DISPLAYING; ADVERTISING; SIGNS; LABELS OR NAME-PLATES; SEALS).
The verdict
Rekon holds 23 US patents across 18 technology areas, rank #13,124 of 50,000 tracked assignees.
Rekon, Llc has been granted 23 US utility patents between 2023 and 2025, placing Rekon, Llc at rank #13,124 across all assignees tracked by PlainPatent. This portfolio spans 18 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.9 claims per patent with primary concentration in G09F (DISPLAYING; ADVERTISING; SIGNS; LABELS OR NAME-PLATES; SEALS). As a US Corporation, Rekon, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Rekon sits between RED BEND Ltd. (23 patents, rank #13,120) and Rosemount Analytical Inc. (23 patents, rank #13,128) - the closest US assignees by grant volume. The composite Innovation Score of 53.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2023 through 2025, with 23 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Rekon, Llc's 12.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 18 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Rekon, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
RED BEND LTD.
23 patents
REXAM BEVERAGE CAN COMPANY
23 patents
RFHIC Corporation
23 patents
RapidDeploy, Inc.
23 patents
Rich Products Corporation
23 patents
Robert T. and Virginia T. Jenkins
23 patents
Roche Palo Alto LLC
23 patents
Rosemount Analytical Inc.
23 patents
Rekon, LLC
23 patents
What this shows Rekon holds 23 patents at rank #13,124, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #13,124 in granted patent volume.
Other assignees with the most granted patents in Rekon's primary technology class.
Rekon's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
54 Top 9% higher than 91% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 6 | 26.1% |
| 2024 | 9 | 39.1% |
| 2025 | 8 | 34.8% |
Top 15 of 18 technology areas
Overall rank by patents
#13,124
Across all tracked assignees
53.7 out of 100
How to use this portfolio
Rekon's 23 grants land it in the top 9% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.